CPDD 78th Annual Scientific Meeting Program

Wednesday, June 15, 2016
17 Pregabalin for opioid detoxification: Interim results
E. Krupitsky 1 , R. Ilyuk 1 , A. Mikhailov 1 , K. Kazankov 1 , K. Rybakova 1 , O. Grishina 1 ,
I. Zaplatkin 4 , D. Langelben 3 , G. E. Woody 3 , 1 St. Petersburg VM Bekhterev Research
Psychoneurological Institute, St. Petersburg, Russian Federation, 3 Psychiatry, University of
Pennsylvania Perelman School of Medicine, Philadelphia, PA, 4 Murmansk Regional Addiction
Hospital, Murmansk, Russian Federation
18 The effect of substance use disorders on the association between guideline-concordant longterm
opioid therapy and all-cause mortality
J. R. Gaither 1,2 , J. Goulet 1,2 , W. Becker 1,2 , S. Crystal 3 , E. J. Edelman 1 , K. S. Gordon 2 ,
R. Kerns 1,2 , D. Rimland 4 , M. Skanderson 2 , A. Justice 1,2 , D. A. Fiellin 1 , 1 Yale, New Haven, CT,
2
VA, West Haven, CT, 3 Rutgers, New Brunswick, NJ, 4 Emory, Atlanta, GA
19 Increasing medication use for alcohol and opioid disorders through organizational change
J. H. Ford 2 , A. Abraham 4 , N. Lupulescu-Mann 5 , R. Croff 3 , K. Johnson 2 , M. Chalk 6 ,
L. Schmidt 7 , D. McCarty 1 , 1 CB 669 PHPM, Oregon Health & Science Univ, Portland, OR,
2
University of Wisconsin-Madison, Madison, WI, 3 Public Health & Preventive Medicine,
Oregon Health & Science University, Portland, OR, 4 University of Georgia, Athens, GA,
5
OHSU, Portland, OR, 6 TRI, Philadelphia, PA, 7 UCSF, San Francisco, CA
20 Pay for performance and treatment outcome in medication-assisted treatment
E. Loscalzo, A. Levit, R. Sterling, S. Weinstein, Psychiatry and Human Behavior, Thomas
Jefferson University, Philadelphia, PA
21 Injection heroin use and methadone maintenance treatment outcomes
D. M. Ledgerwood 1 , J. J. Lister 2 , B. V. LaLiberte 1 , M. Greenwald 1 , 1 Psychiatry, Wayne State
School of Medicine, Detroit, MI, 2 Wayne State University, Detroit, MI
22 Comparison of risk behavior, addiction severity, and history of overdose between active and
agonist-maintained heroin users
B. Todhunter 1,3 , K. Wehmeyer 1 , J. D. Jones 3 , S. D. Comer 2 , 1 Psychology, Columbia
University, Teachers College, New York, NY, 2 Psychiatry, Columbia University and NYSPI,
New York, NY, 3 Division of Substance Abuse, New York Psychiatric Institute, Columbia
Medical School, New York, NY
23 Modeling heroin careers over 40 years: Social costs
A. Ritter 1 , V. Hoang 1 , V. Cao 3 , M. Shanahan 1 , N. Shukla 3 , P. Perez 3 , M. Farrell 2 , 1 Drug Policy
Modelling Program, University of New South Wales, Sydney, NSW, Australia, 2 NDARC,
UNSW, Sydney, NSW, Australia, 3 SMART Infrastructure Facility, University of Wollongong,
Wollongong, NSW, Australia
24 Baseline predictors of outpatient induction onto extended-release naltrexone
V. A. Barbieri 2 , K. Mishlen 1 , M. Sullivan 4,3 , A. Bisaga 2 , 1 Substance Abuse, Columbia
University, New York, NY, 2 Substance Abuse, Columbia University/ New York State
Psychiatric Institute, New York, NY, 3 Columbia University, New York, NY, 4 Alkermes, Inc.,
Waltham, MA
25 Opioid use following an outpatient detoxification and induction onto XR-NTX: Testing the
blockade as a predictor of retention in treatment
K. Mishlen 1 , V. A. Barbieri 1 , M. A. Sullivan 2,3 , A. Bisaga 1 , 1 Substance Abuse, Columbia
University/ New York State Psychiatric Institute, New York, NY, 2 Alkermes, Inc.,
Waltham, MA, 3 Columbia University, New York, NY
26 Employment-based reinforcement of naltrexone adherence in unemployed heroin users: Effects
on opiate use
B. Jarvis, A. Holtyn, A. DeFulio, A. Umbricht, M. Fingerhood, G. Bigelow, K. Silverman,
Johns Hopkins University School of Medicine, Baltimore, MD
78